Cheryl Cui recently graduated with a BASc. in Biomedical Engineering from the University of Toronto. Cheryl is passionate about bringing medical innovations to the world and to deliver these technologies, with equality, to everyone. Last summer, Cheryl worked at Innovations in International Health at MIT, where she developed a paper-‐based diagnostic chip for monitoring patient’s compliance with tuberculosis treatment. In collaboration with Harvard Medical School, she established the Kidney Disease Screening and Awareness Program, the first community health screening program at University of Toronto. Cheryl has a strong commitment to biomedical research. During an internship year at the Harvard-‐MIT division of Health Science and Technology, she co-‐authored two research articles published in high impact journals including Nature Nanotechnology. Cheryl also has two patents pending on cancer detection and cellular engineering techniques.